#liver cancer

Liver cancer development is strongly associated with hep B.

Cure rates were near 100 percent even though the population in the study’s analysis had high rates of other health conditions.

Recommendations now include multiple systemic medications in addition to surgery and local therapies.

Compared with their HIV-negative peers, HIV-positive individuals have higher rates of treatment for a host of health problems.

This finding is specific to those who do not have liver cancer.

Study shows VEGF inhibitor is effective for patients with a biomarker of poor prognosis.

Previous research indicated that compared with interferon-based treatment, direct-acting antiviral treatment raised this risk.

Controversial ruling relates to a chemical produced in the roasting process.

A look at exciting cancer research from the 2018 Conference on Retroviruses and Opportunistic Infections

Liver cancer is a growing problem worldwide but new treatments show promise.

Use of drugs like Nexium or Prilosec is tied to progression to cirrhosis, decompensated cirrhosis and liver cancer in this population.